The latest poll from the brokerage giant finds the economy is the top issue for affluent investors as well as business owners ...

Italy's Treasury said on Friday it had picked UBS Europe SE and White & Case Europe LLP as financial and legal advisers for ...

Certara (CERT) stock rises 10% after UBS upgrade to Buy citing strong growth potential in biosimulation software and Model ...

Stealth BioTherapeutics Inc. (the "Company" or "Stealth"), a clinical-stage biotechnology company focused on the discovery, ...

Through the breadth of its market liquidity, product scale and global footprint, UBS has built a strong reputation as the ...

UBS has demonstrated resilience and adaptability in the face of significant organizational changes and challenging market ...

UBS is in talks to form an Indian wealth management joint venture with Mumbai-based 360 One WAM, two sources with direct ...

Fintel reports that on September 27, 2024, UBS downgraded their outlook for Medpace Holdings (NasdaqGS:MEDP) from Buy to ...

Fintel reports that on September 27, 2024, UBS upgraded their outlook for Certara (NasdaqGS:CERT) from Neutral to Buy.

Los Angeles had the fourth highest risk of being in a housing bubble of 25 major cities across the globe, according to ...

Novartis (SIX:NOVN), and other stocks could present surprises to investors during the third quarter earnings season, as per analysts at UBS. The analysts flag several key factors that could influence ...

UBS has maintained a sell rating on Hero MotoCorp with a target price of ₹3,350, citing concerns over declining retail market ...